These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 18386774)

  • 1. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
    Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
    Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors.
    Rodriguez-Nieto S; Cañada A; Pros E; Pinto AI; Torres-Lanzas J; Lopez-Rios F; Sanchez-Verde L; Pisano DG; Sanchez-Cespedes M
    Hum Mutat; 2011 Feb; 32(2):E1999-2017. PubMed ID: 21280140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
    Rodriguez-Nieto S; Sanchez-Cespedes M
    Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
    Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E
    Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
    Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
    Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
    Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
    Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
    Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
    Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
    Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the BRG1 gene in prostate cancer clinical samples.
    Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
    Int J Oncol; 2003 May; 22(5):1003-7. PubMed ID: 12684665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.
    Liu CX; Musco S; Lisitsina NM; Forgacs E; Minna JD; Lisitsyn NA
    Cancer Res; 2000 Apr; 60(7):1961-7. PubMed ID: 10766186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.
    Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N
    Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.